Last 12 months
Inside the activity.
0 purchase rows · 27 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 11 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 23, 2023 Filed Oct 24, 2023 21:22 UTC |
Kassberg Thomas RichardCBO & EVP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 39,878 | $0.00 Strike: $6.86 | $0.00 |
DisclosureSEC source: 0001209191-23-053487 · doc4.xml · derivative · entry 3 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,878 shares Expires 2023-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested with respect to 1/4th of the shares on the first anniversary of the grant date of the option and 1/48th of the shares thereafter such that the option fully vested on the fourth anniversary of the grant date. Read SEC document |
| October 23, 2023 Filed Oct 24, 2023 21:22 UTC |
Kassberg Thomas RichardCBO & EVP
|
SaleCommon Stock | 39,878 | $32.78 | $1,307,200.84 |
DisclosureSEC source: 0001209191-23-053487 · doc4.xml · nonDerivative · entry 2 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 246,860 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.09 to $33.18 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| October 23, 2023 Filed Oct 24, 2023 21:22 UTC |
Kassberg Thomas RichardCBO & EVP
|
Exercise / conversionCommon Stock | 39,878 | $6.86 | $273,563.08 |
DisclosureSEC source: 0001209191-23-053487 · doc4.xml · nonDerivative · entry 1 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 19, 2023 Filed Oct 23, 2023 21:14 UTC |
KAKKIS EMIL DDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 47,853 | $0.00 Strike: $6.86 | $0.00 |
DisclosureSEC source: 0001209191-23-053351 · doc4.xml · derivative · entry 4 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,853 shares Expires 2023-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested with respect to 1/4th of the shares on the first anniversary of the grant date of the option and 1/48th of the shares thereafter such that the option fully vested on the fourth anniversary of the grant date. Read SEC document |
| October 19, 2023 Filed Oct 23, 2023 21:14 UTC |
KAKKIS EMIL DDirector · President & CEO
|
SaleCommon Stock | 47,853 | $33.52 | $1,604,032.56 |
DisclosureSEC source: 0001209191-23-053351 · doc4.xml · nonDerivative · entry 2 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 599,743 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.57 to $34.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Includes 567 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2023. F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| October 19, 2023 Filed Oct 23, 2023 21:14 UTC |
KAKKIS EMIL DDirector · President & CEO
|
Exercise / conversionCommon Stock | 47,853 | $6.86 | $328,271.58 |
DisclosureSEC source: 0001209191-23-053351 · doc4.xml · nonDerivative · entry 1 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 647,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023. Read SEC document |
| October 09, 2023 Filed Oct 10, 2023 16:50 UTC |
Horn HowardChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 140,469 | $0.00 Strike: $35.68 | $0.00 |
DisclosureSEC source: 0001209191-23-052466 · doc4.xml · derivative · entry 2 Horn Howard · CIK 0001786335 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,469 Underlying: Common Stock · 140,469 shares Expires 2033-10-09 F2 · derivative.exercise_date: The option shall vest with respect to 1/4th of the shares on the first anniversary of the grant date of the option and 1/48th of the shares initially subject to the option shall continue to vest on each month such that the option will fully vest on the fourth anniversary of the grant date. Read SEC document |
| October 09, 2023 Filed Oct 10, 2023 16:50 UTC |
Horn HowardChief Financial Officer
|
GrantCommon Stock | 80,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052466 · doc4.xml · nonDerivative · entry 1 Horn Howard · CIK 0001786335 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,336 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's Employment Inducement Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. Read SEC document |
| September 27, 2023 Filed Sep 29, 2023 18:16 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 2,351 | $0.00 Strike: $67.37 | $0.00 |
DisclosureSEC source: 0001209191-23-050841 · doc4.xml · derivative · entry 2 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,351 Underlying: Common Stock · 2,351 shares Expires 2027-03-01 F2 · derivative.exercise_date: On March 1, 2022, the Reporting Person was granted an option to purchase 2,351 shares of common stock. The option vests upon the achievement of specified performance criteria. Upon achievement of the performance criteria, 1/3 of the option vests on the date of certification by the Issuer's compensation committee of achievement of the performance criteria, 1/3 of the option vests on March 1, 2024 and 1/3 of the option vests on March 1, 2025. On September 27, 2023, the Issuer's compensation committee certified achievement of the performance criteria for the option, resulting in the vesting of the option of 784 shares on that date. Read SEC document |
| September 27, 2023 Filed Sep 29, 2023 18:15 UTC |
Crombez EricEVP and Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 2,351 | $0.00 Strike: $67.37 | $0.00 |
DisclosureSEC source: 0001209191-23-050840 · doc4.xml · derivative · entry 2 Crombez Eric · CIK 0001653052 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,351 Underlying: Common Stock · 2,351 shares Expires 2027-03-01 F2 · derivative.exercise_date: On March 1, 2022, the Reporting Person was granted an option to purchase 2,351 shares of common stock. The option vests upon the achievement of specified performance criteria. Upon achievement of the performance criteria, 1/3 of the option vests on the date of certification by the Issuer's compensation committee of achievement of the performance criteria, 1/3 of the option vests on March 1, 2024 and 1/3 of the option vests on March 1, 2025. On September 27, 2023, the Issuer's compensation committee certified achievement of the performance criteria for the option, resulting in the vesting of the option of 784 shares on that date. Read SEC document |
| September 07, 2023 Filed Sep 11, 2023 17:52 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $21.00 | $0.00 |
DisclosureSEC source: 0001209191-23-048905 · doc4.xml · derivative · entry 4 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 2,000 shares Expires 2024-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter. Read SEC document |
| September 07, 2023 Filed Sep 11, 2023 17:52 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
SaleCommon Stock | 163 | $38.34 | $6,249.42 |
DisclosureSEC source: 0001209191-23-048905 · doc4.xml · nonDerivative · entry 3 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,614 F2 · balance_after: Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| September 07, 2023 Filed Sep 11, 2023 17:52 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
SaleCommon Stock | 2,000 | $41.00 | $82,000.00 |
DisclosureSEC source: 0001209191-23-048905 · doc4.xml · nonDerivative · entry 2 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,777 Read SEC document |
| September 07, 2023 Filed Sep 11, 2023 17:52 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 2,000 | $21.00 | $42,000.00 |
DisclosureSEC source: 0001209191-23-048905 · doc4.xml · nonDerivative · entry 1 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 21:51 UTC |
Harris ErikEVP & Chief Commercial Officer
|
SaleCommon Stock | 6,000 | $37.96 | $227,760.00 |
DisclosureSEC source: 0001209191-23-048491 · doc4.xml · nonDerivative · entry 1 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,281 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.95 to $38.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · balance_after: Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 21:50 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
SaleCommon Stock | 87 | $38.23 | $3,326.01 |
DisclosureSEC source: 0001209191-23-048489 · doc4.xml · nonDerivative · entry 2 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,777 F2 · shares: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). F3 · balance_after: The total amount of securities beneficially owned by the Reporting Person reflected in Table 1, Column 5 of this Form 4 reflects the correction of a typographical error in a previously filed Form 4 filed on April 18, 2023 ("April 2023 Form 4"). The corrected total amount of securities beneficially owned by the Reporting Person in Table 1, Column 5 of the April 2023 Form 4 is 21,520. The corrected total amount of securities beneficially owned by the Reported Person in Table 1, Column 5 of the Form 4 filed on behalf of the Reporting Person on May 10, 2023 is 24,747. F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 21:50 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
SaleCommon Stock | 883 | $37.04 | $32,706.32 |
DisclosureSEC source: 0001209191-23-048489 · doc4.xml · nonDerivative · entry 1 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,864 F1 · shares: The sale reported on this row of the Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023. Read SEC document |
| June 30, 2023 Filed Jun 30, 2023 18:34 UTC |
Sanders Corazon (Corsee) D.Director
|
SaleCommon Stock | 585 | $46.76 | $27,354.60 |
DisclosureSEC source: 0001209191-23-040269 · doc4.xml · nonDerivative · entry 1 Sanders Corazon (Corsee) D. · CIK 0001796536 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,985 F1 · shares: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023. Read SEC document |
| June 19, 2023 Filed Jun 21, 2023 22:17 UTC |
Harris ErikEVP & Chief Commercial Officer
|
SaleCommon Stock | 305 | $48.20 | $14,701.00 |
DisclosureSEC source: 0001209191-23-038885 · doc4.xml · nonDerivative · entry 1 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,281 F1 · shares: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes 242 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2023. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 18:31 UTC |
Sanders Corazon (Corsee) D.Director
|
SaleCommon Stock | 1,485 | $51.65 | $76,700.25 |
DisclosureSEC source: 0001209191-23-035690 · doc4.xml · nonDerivative · entry 2 Sanders Corazon (Corsee) D. · CIK 0001796536 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,570 F2 · shares: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 14:33 UTC |
Ray AmritDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,110 | $0.00 Strike: $51.82 | $0.00 |
DisclosureSEC source: 0001209191-23-035692 · doc4.xml · derivative · entry 2 Ray Amrit · CIK 0001924797 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 7,110 shares Expires 2033-06-07 F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 14:33 UTC |
Ray AmritDirector
|
GrantCommon Stock | 3,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035692 · doc4.xml · nonDerivative · entry 1 Ray Amrit · CIK 0001924797 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,280 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 18:28 UTC |
WELCH DANIEL GDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,110 | $0.00 Strike: $51.82 | $0.00 |
DisclosureSEC source: 0001209191-23-035686 · doc4.xml · derivative · entry 2 WELCH DANIEL G · CIK 0001206199 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 7,110 shares Expires 2033-06-07 F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 18:28 UTC |
WELCH DANIEL GDirector
|
GrantCommon Stock | 3,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035686 · doc4.xml · nonDerivative · entry 1 WELCH DANIEL G · CIK 0001206199 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,605 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 18:29 UTC |
Dunsire DeborahDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,110 | $0.00 Strike: $51.82 | $0.00 |
DisclosureSEC source: 0001209191-23-035687 · doc4.xml · derivative · entry 2 Dunsire Deborah · CIK 0001332764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 7,110 shares Expires 2033-06-07 F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024 Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 18:29 UTC |
Dunsire DeborahDirector
|
GrantCommon Stock | 3,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035687 · doc4.xml · nonDerivative · entry 1 Dunsire Deborah · CIK 0001332764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,730 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 14:30 UTC |
NARACHI MICHAELDirector
|
GrantCommon Stock · Derivative | 7,110 | $0.00 Strike: $51.82 | $0.00 |
DisclosureSEC source: 0001209191-23-035688 · doc4.xml · derivative · entry 2 NARACHI MICHAEL · CIK 0001380022 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 7,110 shares Expires 2033-06-07 F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 14:30 UTC |
NARACHI MICHAELDirector
|
GrantCommon Stock | 3,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035688 · doc4.xml · nonDerivative · entry 1 NARACHI MICHAEL · CIK 0001380022 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,605 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 18:32 UTC |
Fust Matthew KDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,110 | $0.00 Strike: $51.82 | $0.00 |
DisclosureSEC source: 0001209191-23-035691 · doc4.xml · derivative · entry 3 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 7,110 shares Expires 2033-06-07 F3 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 18:32 UTC |
Fust Matthew KDirector
|
Disposition to issuerCommon Stock | 3,300 | $51.82 | $171,006.00 |
DisclosureSEC source: 0001209191-23-035691 · doc4.xml · nonDerivative · entry 2 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,055 F2 · shares: Shares were acquired upon the vesting of a previously reported RSU and were disposed of to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 18:32 UTC |
Fust Matthew KDirector
|
GrantCommon Stock | 3,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035691 · doc4.xml · nonDerivative · entry 1 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,355 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 18:31 UTC |
Sanders Corazon (Corsee) D.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,110 | $0.00 Strike: $51.82 | $0.00 |
DisclosureSEC source: 0001209191-23-035690 · doc4.xml · derivative · entry 3 Sanders Corazon (Corsee) D. · CIK 0001796536 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 7,110 shares Expires 2033-06-07 F3 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 18:31 UTC |
Sanders Corazon (Corsee) D.Director
|
GrantCommon Stock | 3,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035690 · doc4.xml · nonDerivative · entry 1 Sanders Corazon (Corsee) D. · CIK 0001796536 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,055 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 18:30 UTC |
SULIMAN SHEHNAAZDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,110 | $0.00 Strike: $51.82 | $0.00 |
DisclosureSEC source: 0001209191-23-035689 · doc4.xml · derivative · entry 2 SULIMAN SHEHNAAZ · CIK 0001713070 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 7,110 shares Expires 2033-06-07 F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 18:30 UTC |
SULIMAN SHEHNAAZDirector
|
GrantCommon Stock | 3,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035689 · doc4.xml · nonDerivative · entry 1 SULIMAN SHEHNAAZ · CIK 0001713070 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,855 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024. Read SEC document |
| May 18, 2023 Filed May 19, 2023 17:54 UTC |
Pinion John RichardSee Remarks
|
SaleCommon Stock | 2,012 | $50.00 | $100,600.00 |
DisclosureSEC source: 0001209191-23-030931 · doc4.xml · nonDerivative · entry 1 Pinion John Richard · CIK 0001648096 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,744 F1 · shares: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023. F2 · balance_after: Includes 596 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2023. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| May 09, 2023 Filed May 11, 2023 00:09 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $21.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028585 · doc4.xml · derivative · entry 2 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 3,000 shares Expires 2024-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter. Read SEC document |
| May 09, 2023 Filed May 11, 2023 00:09 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 3,000 | $21.00 | $63,000.00 |
DisclosureSEC source: 0001209191-23-028585 · doc4.xml · nonDerivative · entry 1 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 227 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2023. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| May 04, 2023 Filed May 5, 2023 18:16 UTC |
Parschauer Karah HerdmanEVP and Chief Legal Officer
|
SaleCommon Stock | 4,378 | $45.00 | $197,010.00 |
DisclosureSEC source: 0001209191-23-027601 · doc4.xml · nonDerivative · entry 1 Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,982 F1 · shares: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023. F2 · balance_after: Includes 221 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2023. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| May 01, 2023 Filed May 2, 2023 22:18 UTC |
Crombez EricEVP and Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 8,362 | $0.00 Strike: $44.03 | $0.00 |
DisclosureSEC source: 0001209191-23-026692 · doc4.xml · derivative · entry 2 Crombez Eric · CIK 0001653052 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,362 Underlying: Common Stock · 8,362 shares Expires 2033-05-01 F3 · derivative.exercise_date: The option shall vest with respect to 1/4th of the shares on the first anniversary of the grant date of the option and 1/48th of the shares initially subject to the option shall continue to vest on each month such that the option will fully vest on the fourth anniversary of the grant date. Read SEC document |
| May 01, 2023 Filed May 2, 2023 22:18 UTC |
Crombez EricEVP and Chief Medical Officer
|
GrantCommon Stock | 4,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026692 · doc4.xml · nonDerivative · entry 1 Crombez Eric · CIK 0001653052 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,512 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| April 16, 2023 Filed Apr 18, 2023 20:57 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
Disposition to issuerCommon Stock | 181 | $38.20 | $6,914.20 |
DisclosureSEC source: 0001209191-23-024685 · doc4.xml · nonDerivative · entry 2 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,520 F2 · shares: Shares were acquired upon the partial vesting of a previously reported RSU and were sold to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| April 16, 2023 Filed Apr 18, 2023 20:57 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 14 | $38.20 | $534.80 |
DisclosureSEC source: 0001209191-23-024685 · doc4.xml · nonDerivative · entry 1 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,701 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:57 UTC |
Kassberg Thomas RichardCBO & EVP
|
GrantStock Option (Right to Buy) · Derivative | 39,400 | $0.00 Strike: $45.65 | $0.00 |
DisclosureSEC source: 0001209191-23-016046 · doc4.xml · derivative · entry 5 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,400 Underlying: Common Stock · 39,400 shares Expires 2033-03-01 F6 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:57 UTC |
Kassberg Thomas RichardCBO & EVP
|
Disposition to issuerCommon Stock | 3,394 | $45.65 | $154,936.10 |
DisclosureSEC source: 0001209191-23-016046 · doc4.xml · nonDerivative · entry 4 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,860 F4 · shares: Shares were acquired upon the partial vesting of a previously reported RSU and were sold to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person F5 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:57 UTC |
Kassberg Thomas RichardCBO & EVP
|
SaleCommon Stock | 1,968 | $45.27 | $89,091.36 |
DisclosureSEC source: 0001209191-23-016046 · doc4.xml · nonDerivative · entry 3 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,254 F3 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:57 UTC |
Kassberg Thomas RichardCBO & EVP
|
GrantCommon Stock | 22,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016046 · doc4.xml · nonDerivative · entry 2 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,222 F2 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:57 UTC |
Kassberg Thomas RichardCBO & EVP
|
GrantCommon Stock | 2,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016046 · doc4.xml · nonDerivative · entry 1 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,222 F1 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:52 UTC |
KAKKIS EMIL DDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 83,500 | $0.00 Strike: $45.65 | $0.00 |
DisclosureSEC source: 0001209191-23-016041 · doc4.xml · derivative · entry 5 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,500 Underlying: Common Stock · 83,500 shares Expires 2033-03-01 F6 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:52 UTC |
KAKKIS EMIL DDirector · President & CEO
|
Tax withholdingCommon Stock | 16,140 | $45.65 | $736,791.00 |
DisclosureSEC source: 0001209191-23-016041 · doc4.xml · nonDerivative · entry 3 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 599,176 F3 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F5 · balance_after: Reflects transfer of directly owned shares of common stock from the Reporting Person to a trust indirectly held by the Reporting Person that have taken place since the most recent prior report on Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.